Growing your life sciences business in the US and China

The pandemic threw the life sciences industry into the spotlight, with the UK emerging as a life sciences superpower.

In fact, UK life science exports were worth £24.2 billion in 2021.

From aging populations to aging equipment and infrastructure, global markets are calling out for innovative technologies to solve their challenges.

No more so than the two largest life sciences markets – the US and China.

Between them, they accounted for almost $500 billion worth of medical imports in 2022.

And your business could be the answer.

But how can you break into these high growth markets?

Join Santander UK and their eco-system of international providers for an exclusive face-to-face seminar which aims to give you invaluable insights and strategies to effectively navigate and thrive in the two largest healthcare markets in the world.

Who is this seminar for?

Companies across the life science sector with innovative products and existing or potential ambitions to grow their business internationally, specifically in the US and/or China.

This includes:

• Advanced medical devices and technologies.
• Digital health solutions.
• Biotech.
• Pharmaceuticals.
   

Join this seminar to:

Discover the market opportunities for your business.
Get tips for navigating the regulatory landscape in both markets.
Explore new partnership opportunities within each market.

The seminar is free-of-charge to attend but subject to confirmation from the event organisers due to limited capacity.